News Updates

More Articles Back to Article

Sep 02, 2026
Industry Perspective on Singapore’s Rise as a Trusted Global Regulatory Leader
Sep 02, 2026
Obesity Drug Development: Time to Revisit Endpoints, Trial Design, and Evidence Generation
Sep 02, 2026
The Data Is Already There: Reimagining Site Source in Clinical Trials
Sep 02, 2026
The Variability Problem: Why Site Selection is a Risk You Cannot See
Sep 02, 2026
Beyond the Speed Gap: What Differentiates Chinese Local Companies and MNCs in Drug Development?

The Variability Problem: Why Site Selection is a Risk You Cannot See

Allocating volume to a single accountable network does not concentrate risk but in fact reduces it, and it does so in ways that align with where regulators are already pushing industry.

Read Article

News Updates

The Variability Problem: Why Site Selection is a Risk You Cannot See

The Variability Problem: Why Site Selection is a Risk You Cannot See

Be informed and stay engaged.